Legend Biotech (LEGN) FCF Payout Ratio (2019 - 2025)
Legend Biotech's (LEGN) quarterly FCF Payout Ratio came in at 0.36 in Q3 2025, up 110.75% YoY from 0.17 in Q3 2024, and up 100.01% on a QoQ basis from 5837.2 in Q2 2025.
Legend Biotech (LEGN) FCF Payout Ratio (2019 - 2025) Analysis & Trends
Legend Biotech (LEGN) has 7 years of FCF Payout Ratio data on file, last reported at 0.36 in Q3 2025.
- Quarterly FCF Payout Ratio rose 110.75% year-over-year to 0.36 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 2.99 (down 196.14% YoY) and the FY2021 annual result came in at 2.85, down 62.33% from the prior year.
- FCF Payout Ratio advanced to 0.36 in Q3 2025, from 5837.2 in the prior quarter.
- In the past five years, FCF Payout Ratio ranged from a high of 357.82 in Q2 2024 to a low of 5837.2 in Q2 2025.
- A 5-year average of 342.52 and a median of 3.78 in 2024 frame the typical range for FCF Payout Ratio.
- Annual changes were most pronounced in 2023 — FCF Payout Ratio slumped 3399.89% — and 2024, when it soared 6257.31%.
- Tracing LEGN's FCF Payout Ratio over 5 years: stood at 4.41 in 2021, then sank by 41.23% to 6.23 in 2022, then soared by 170.71% to 4.4 in 2023, then sank by 176.91% to 3.39 in 2024, then soared by 110.75% to 0.36 in 2025.
- The last three FCF Payout Ratio figures came in at 0.36 (Q3 2025), 5837.2 (Q2 2025), and 4.18 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.17 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.07 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Legend Biotech | 3.95 Bn | 3.27 Bn | 251.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 0.36 |
| Jun 30, 2025 | -5,837.20 |
| Mar 31, 2025 | -4.18 |
| Sep 30, 2024 | -3.39 |
| Jun 30, 2024 | 357.82 |
| Mar 31, 2024 | 41.25 |
| Sep 30, 2023 | 4.40 |
| Jun 30, 2023 | -5.81 |
| Mar 31, 2023 | -4.89 |
| Sep 30, 2022 | -6.23 |
| Jun 30, 2022 | 0.18 |
| Mar 31, 2022 | -4.79 |
| Dec 31, 2021 | -4.41 |
| Sep 30, 2021 | 3.23 |
| Jun 30, 2021 | -1.27 |
| Mar 31, 2021 | -15.40 |
| Dec 31, 2020 | -2.32 |
| Sep 30, 2020 | 1.76 |
| Jun 30, 2020 | -6.92 |
| Mar 31, 2020 | -3.69 |